Tolerance of Vascularized Islet-Kidney Transplants in Rhesus Monkeys
- PMID: 27376692
- PMCID: PMC5195889
- DOI: 10.1111/ajt.13952
Tolerance of Vascularized Islet-Kidney Transplants in Rhesus Monkeys
Abstract
We previously reported that transplantation (Tx) of prevascularized donor islets as composite islet-kidneys (IK) reversed diabetic hyperglycemia in both miniature swine and baboons. In order to enhance this strategy's potential clinical applicability, we have now combined this approach with hematopoietic stem cell (HSC) Tx in an attempt to induce tolerance in nonhuman primates. IKs were prepared by isolating islets from 70% partial pancreatectomies and injecting them beneath the autologous renal capsule of five rhesus monkey donors at least 3 months before allogeneic IK Tx. HSC Tx was performed after mobilization and leukapheresis of the donors and conditioning of the recipients with total body irradiation, T cell depletion, and cyclosporine. One IK was harvested for histologic analysis and four were transplanted into diabetic recipients. IK Tx was performed either 20-22 (n = 3) or 208 (n = 1) days after HSC Tx. All animals accepted IKs without rejection. All recipients required >20 U/day insulin before IK Tx to maintain <200 mg/dL, whereas after IK Tx, three animals required minimal doses of insulin (1-3 U/day) and one animal was insulin free. These results constitute a proof-of-principle that this IK tolerance strategy may provide a cure for both end-stage renal disease and diabetes without the need for immunosuppression.
Keywords: islet isolation; islet transplantation; kidney transplantation/nephrology; tolerance: chimerism; tolerance: experimental; translational research/science.
© Copyright 2016 The American Society of Transplantation and the American Society of Transplant Surgeons.
Conflict of interest statement
The authors of this manuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation.
Figures











Comment in
-
Transplantation: A new tolerance strategy for diabetic recipients.Nat Rev Nephrol. 2016 Sep;12(9):509. doi: 10.1038/nrneph.2016.114. Epub 2016 Jul 18. Nat Rev Nephrol. 2016. PMID: 27425157 No abstract available.
References
-
- Wolfe RA, Ashby VB, Milford EL, Ojo AO, Ettenger RE, Agodoa LY, et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med. 1999;341(23):1725–1730. - PubMed
-
- Ryan EA, Paty BW, Senior PA, Bigam D, Alfadhli E, Kneteman NM, et al. Five-year follow-up after clinical islet transplantation. Diabetes. 2005;54(7):2060–2069. - PubMed
-
- Yamada K, Shimizu A, Utsugi R, Ierino FL, Gargollo P, Haller GW, et al. Thymic transplantation in miniature swine. II. Induction of tolerance by transplantation of composite thymokidneys to thymectomized recipients. J Immunol. 2000;164(6):3079–3086. - PubMed
-
- Yamada K, Vagefi PA, Utsugi R, Kitamura H, Barth RN, LaMattina JC, et al. Thymic transplantation in miniature swine: III. Induction of tolerance by transplantation of composite thymokidneys across fully major histocompatibility complex-mismatched barriers. Transplantation. 2003;76(3):530–536. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical